NCBiotech News

Raleigh's Advanced Chemotherapy Technologies announces $5.5M in Series A to fund tests of its medical device offering targeted delivery of chemotherapy to the pancreas in humans.

Durham startup 410 Medical has received FDA 510(k) Clearance for its LifeFlow PLUS Blood and Fluid Infuser (LifeFlow PLUS). 

Alyssa LaFaro at UNC Research highlights the coronavirus-focused work of Ralph Baric and Timothy Sheahan, Ph.D.

Syneos Health, one of the biggest contract service providers in the sector is getting even bigger through the acquisition of Synteract.

BioAgilytix, one of North Carolina’s fastest-growing home-grown life sciences companies, is adding 878 new employees with a $61.5 million investment in its global Durham headquarters.

Elizabeth City life sciences company IngateyGen is led by Hortense Dodo, Ph.D., who is using CRISPR technology supported by NCBiotech to take the allergic reactions out of peanuts.

The North Carolina Economic Development Association today honored the North Carolina Biotechnology Center's Laura Rowley, Ph.D., as the Emerging Leader of the Year for her successes in attracting and retaining life sciences companies.

Holly Springs biotech startup Avior Bio says its Phase 1 clinical trial shows its chronic itch therapy is “safe and tolerable.”

Raleigh ag tech company Genoverde Biosciences has shifted focus during COVID-19, using its facilities and tech to provide hand sanitizers to communities in need.

Gene therapy pioneer AskBio of Chapel Hill, supported in its early years by NCBiotech, will be acquired by Bayer AG, the German healthcare and ag conglomerate, for up to $4 billion.

Durham's Tellus Therapeutics has received Orphan Drug and Rare Pediatric Drug designations from the FDA for its neonatal brain injury treatment.

Durham's Emergo has just received $3.5 million in equity backing from 77 investors for a new clinical study to see how the therapy works on patients with flu-like symptoms.

Burlington-based LabCorp has launched a new antibody test for research labs, the latest in a string of contributions to the fight against SARS-CoV-2, the virus that causes COVID-19.

MED-EL Medical Electronics, a hearing-technology company with U.S. headquarters in Durham, was recently named “Innovator of the Year” by the online publication Hearing Health & Technology Matters.

Scientists now have a complete genetic blueprint to help them better understand the western flower thrips and to find ways to control the pest.